“We can sometimes forget why technology matters beyond helping us do our work faster and cheaper; it is because technology tools help us connect with patients, our most important end customers. By including a discussion on patients and patient centricity in their book, Simon and Giovannetti remind us that technology is a powerful way to connect us with them. The recent emergence of patient engagement, sophistication and empowerment means that any healthcare leader must be prepared to genuinely understand the needs of patients, and be prepared to engage with them to improve their health outcomes. This book nicely maps out how technology can be used to meet those goals.”

Olivier Brandicourt, MD, Board Member, Pharmaceutical Research and Manufacturers of America

“Biotech innovation is rapidly embracing digital technologies in the discovery, validation, clinical and product commercialization phases. The Internet of Things is bringing forward the Internet of Medical Things and the opportunities to build value with combinations of molecules, software and devices have never been so evident. Personalization, precision, data analytics and elements of consumer convenience are making their way into product pipelines. Industry participants can use this book as a modern roadmap to innovation and commercialization.”

Donald Jones, Chief Digital Officer, Scripps Translational Science Institute and Chairman, Cardiff Ocean Group

“This is an unprecedented moment in the healthcare industry. Simon and Giovannetti have captured the tremendous potential of the period in this innovative and well-informed book, where they have brought to life the need to leverage digital technology and patient centricity to drive better health outcomes.”

Lynn O'Connor Vos, CEO Greyhealth Group

“If you want to know where biopharma is going, read this book! Our industry is facing unprecedented opportunities driven by major scientific breakthroughs, while transforming itself to address accelerated landscape changes driven by digital revolutions and the emergence of value-based healthcare worldwide. In this ever-changing context, we all need to focus everything we do on the patients. They are why we exist as an industry, and this is ultimately what this insightful essay is really about.”

Emmanuel Blin, former Chief Strategy Officer and Senior Vice President, Bristol-Myers Squibb

“This expert and thorough analysis of the journey from biomedical investigation to patient care presents an innovative blueprint for streamlining, redesigning, and amplifying the process. Specific examples of success stories support the recommendations for improved networking among the various players in the medical arena. Essentially, the authors predict a shift from emphasis on drug development to a broader collaborative system focused on the individual patient. The book is an interesting and important read for anyone involved in the prevention and treatment of disease.”

Marianne J. Legato, MD, PhD (hon. c.), FACP, Emerita Professor of Clinical Medicine, Columbia University Founder and President, Foundation for Gender-Based Medicine

“Precision Medicine, Patient Centricity, Digital Health, Value-Based Reimbursement, Risk-Sharing—these terms were virtually unused in biopharma even five years ago. This book provides essential grounding and concepts to consider for anyone interested in healthcare, drug development and patient access in the 21^st Century.”

Ron Cohen, MD, Former Chairman, Biotechnology Innovation Organization